HK Stock MarketDetailed Quotes

ZHONG AO HOME (01538)

Watchlist
  • 0.720
  • -0.010-1.37%
Market Closed May 14 13:15 CST
615.28MMarket Cap5.67P/E (TTM)

ZHONG AO HOME (01538) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q6)Jun 30, 2025
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
Turnover
3.61%1.84B
1.13%899.48M
4.06%1.78B
3.85%889.46M
0.43%1.71B
4.30%856.52M
-9.13%1.7B
-11.86%821.18M
6.92%1.87B
11.04%931.7M
Operating income
3.61%1.84B
1.13%899.48M
4.06%1.78B
3.85%889.46M
0.43%1.71B
4.30%856.52M
-9.13%1.7B
-11.86%821.18M
6.92%1.87B
11.04%931.7M
Cost of sales
-3.34%-1.46B
-0.44%-704.93M
-3.91%-1.41B
-4.62%-701.84M
-1.04%-1.36B
-7.19%-670.86M
6.65%-1.35B
9.13%-625.85M
-9.93%-1.44B
-13.78%-688.76M
Operating expenses
-3.34%-1.46B
-0.44%-704.93M
-3.91%-1.41B
-4.62%-701.84M
-1.04%-1.36B
-7.19%-670.86M
6.65%-1.35B
9.13%-625.85M
-9.93%-1.44B
-13.78%-688.76M
Gross profit
4.64%383.85M
3.70%194.56M
4.64%366.81M
1.05%187.62M
-1.90%350.56M
-4.95%185.66M
-17.42%357.36M
-19.60%195.34M
-2.02%432.74M
3.94%242.94M
Selling expenses
57.77%-3.08M
-981.87%-1.97M
-12.48%-7.3M
-45.60%-182K
-29.40%-6.49M
93.11%-125K
59.44%-5.01M
76.17%-1.81M
1.74%-12.36M
-19.34%-7.61M
Administrative expenses
2.93%-200.4M
9.81%-87.16M
-7.33%-206.45M
-2.67%-96.64M
8.47%-192.35M
-0.28%-94.13M
7.56%-210.14M
18.21%-93.87M
4.65%-227.32M
-13.37%-114.77M
Impairment and provision
27.52%-29.78M
-25.70%-29.48M
29.95%-41.09M
10.41%-23.45M
-8.43%-58.66M
-20.61%-26.18M
-67.46%-54.1M
-12.70%-21.7M
-41.47%-32.31M
48.95%-19.26M
-Other impairment is provision
27.52%-29.78M
-25.70%-29.48M
29.95%-41.09M
10.41%-23.45M
-8.43%-58.66M
-20.61%-26.18M
-67.46%-54.1M
-12.70%-21.7M
-41.47%-32.31M
48.95%-19.26M
Operating interest expense
----
----
----
----
----
----
----
---1.45M
64.69%-6.38M
----
Special items of operating profit
-96.32%960K
13.46%12.27M
-18.42%26.12M
-15.92%10.81M
-25.39%32.02M
-20.17%12.86M
32.10%42.92M
-19.30%16.11M
-35.09%32.49M
-25.71%19.96M
Operating profit
9.74%151.54M
12.88%88.22M
10.40%138.1M
0.09%78.16M
-4.53%125.08M
-15.68%78.09M
-29.88%131.02M
-23.64%92.61M
-6.48%186.87M
5.20%121.27M
Financing cost
13.56%-2.05M
0.69%-865K
29.95%-2.37M
8.41%-871K
-17.20%-3.38M
---951K
---2.88M
----
----
42.81%-5.06M
Share of profits of associates
33.86%506K
-147.15%-1.34M
126.35%378K
317.14%2.84M
-87.24%167K
-470.25%-1.31M
9.63%1.31M
-31.98%353K
465.88%1.19M
41.80%519K
Share of profit from joint venture company
-73.62%626K
-260.92%-906K
-16.38%2.37M
-80.58%563K
-10.39%2.84M
8.94%2.9M
12.15%3.17M
9.42%2.66M
8.82%2.82M
36.17%2.43M
Special items of earning before tax
----
----
----
----
----
----
----
----
----
-872.67%-4.48M
Earning before tax
8.77%150.63M
5.49%85.11M
11.04%138.48M
2.49%80.69M
-5.96%124.71M
-17.67%78.73M
-30.53%132.61M
-16.62%95.62M
-5.79%190.88M
6.06%114.68M
Tax
18.53%-37.76M
-8.06%-26.22M
-13.79%-46.35M
3.40%-24.27M
6.49%-40.74M
14.09%-25.12M
25.97%-43.56M
8.19%-29.24M
-13.51%-58.84M
3.53%-31.84M
After-tax profit from continuing operations
22.51%112.86M
4.38%58.89M
9.71%92.13M
5.25%56.42M
-5.70%83.97M
-19.24%53.61M
-32.56%89.05M
-19.86%66.38M
-12.43%132.04M
10.28%82.83M
Earning after tax
22.51%112.86M
4.38%58.89M
9.71%92.13M
5.25%56.42M
-5.70%83.97M
-19.24%53.61M
-32.56%89.05M
-19.86%66.38M
-12.43%132.04M
10.28%82.83M
Minority profit
354.40%14.68M
6.27%5.97M
-17.56%3.23M
10.75%5.61M
-67.73%3.92M
-8.85%5.07M
-52.86%12.14M
-59.86%5.56M
33.66%25.76M
11.04%13.85M
Profit attributable to shareholders
10.45%98.19M
4.17%52.93M
11.05%88.9M
4.67%50.81M
4.09%80.05M
-20.19%48.54M
-27.64%76.91M
-11.82%60.82M
-19.18%106.28M
10.13%68.98M
Basic earnings per share
10.58%0.115
5.08%0.062
10.64%0.104
3.51%0.059
4.44%0.094
-19.72%0.057
-27.42%0.09
-12.35%0.071
-21.02%0.124
6.58%0.081
Diluted earnings per share
10.58%0.115
5.08%0.062
10.64%0.104
3.51%0.059
4.44%0.094
-19.72%0.057
-27.42%0.09
-12.35%0.071
-21.02%0.124
6.58%0.081
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Dec 31, 2025(Q6)Jun 30, 2025(FY)Dec 31, 2024(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021
Turnover 3.61%1.84B1.13%899.48M4.06%1.78B3.85%889.46M0.43%1.71B4.30%856.52M-9.13%1.7B-11.86%821.18M6.92%1.87B11.04%931.7M
Operating income 3.61%1.84B1.13%899.48M4.06%1.78B3.85%889.46M0.43%1.71B4.30%856.52M-9.13%1.7B-11.86%821.18M6.92%1.87B11.04%931.7M
Cost of sales -3.34%-1.46B-0.44%-704.93M-3.91%-1.41B-4.62%-701.84M-1.04%-1.36B-7.19%-670.86M6.65%-1.35B9.13%-625.85M-9.93%-1.44B-13.78%-688.76M
Operating expenses -3.34%-1.46B-0.44%-704.93M-3.91%-1.41B-4.62%-701.84M-1.04%-1.36B-7.19%-670.86M6.65%-1.35B9.13%-625.85M-9.93%-1.44B-13.78%-688.76M
Gross profit 4.64%383.85M3.70%194.56M4.64%366.81M1.05%187.62M-1.90%350.56M-4.95%185.66M-17.42%357.36M-19.60%195.34M-2.02%432.74M3.94%242.94M
Selling expenses 57.77%-3.08M-981.87%-1.97M-12.48%-7.3M-45.60%-182K-29.40%-6.49M93.11%-125K59.44%-5.01M76.17%-1.81M1.74%-12.36M-19.34%-7.61M
Administrative expenses 2.93%-200.4M9.81%-87.16M-7.33%-206.45M-2.67%-96.64M8.47%-192.35M-0.28%-94.13M7.56%-210.14M18.21%-93.87M4.65%-227.32M-13.37%-114.77M
Impairment and provision 27.52%-29.78M-25.70%-29.48M29.95%-41.09M10.41%-23.45M-8.43%-58.66M-20.61%-26.18M-67.46%-54.1M-12.70%-21.7M-41.47%-32.31M48.95%-19.26M
-Other impairment is provision 27.52%-29.78M-25.70%-29.48M29.95%-41.09M10.41%-23.45M-8.43%-58.66M-20.61%-26.18M-67.46%-54.1M-12.70%-21.7M-41.47%-32.31M48.95%-19.26M
Operating interest expense -------------------------------1.45M64.69%-6.38M----
Special items of operating profit -96.32%960K13.46%12.27M-18.42%26.12M-15.92%10.81M-25.39%32.02M-20.17%12.86M32.10%42.92M-19.30%16.11M-35.09%32.49M-25.71%19.96M
Operating profit 9.74%151.54M12.88%88.22M10.40%138.1M0.09%78.16M-4.53%125.08M-15.68%78.09M-29.88%131.02M-23.64%92.61M-6.48%186.87M5.20%121.27M
Financing cost 13.56%-2.05M0.69%-865K29.95%-2.37M8.41%-871K-17.20%-3.38M---951K---2.88M--------42.81%-5.06M
Share of profits of associates 33.86%506K-147.15%-1.34M126.35%378K317.14%2.84M-87.24%167K-470.25%-1.31M9.63%1.31M-31.98%353K465.88%1.19M41.80%519K
Share of profit from joint venture company -73.62%626K-260.92%-906K-16.38%2.37M-80.58%563K-10.39%2.84M8.94%2.9M12.15%3.17M9.42%2.66M8.82%2.82M36.17%2.43M
Special items of earning before tax -------------------------------------872.67%-4.48M
Earning before tax 8.77%150.63M5.49%85.11M11.04%138.48M2.49%80.69M-5.96%124.71M-17.67%78.73M-30.53%132.61M-16.62%95.62M-5.79%190.88M6.06%114.68M
Tax 18.53%-37.76M-8.06%-26.22M-13.79%-46.35M3.40%-24.27M6.49%-40.74M14.09%-25.12M25.97%-43.56M8.19%-29.24M-13.51%-58.84M3.53%-31.84M
After-tax profit from continuing operations 22.51%112.86M4.38%58.89M9.71%92.13M5.25%56.42M-5.70%83.97M-19.24%53.61M-32.56%89.05M-19.86%66.38M-12.43%132.04M10.28%82.83M
Earning after tax 22.51%112.86M4.38%58.89M9.71%92.13M5.25%56.42M-5.70%83.97M-19.24%53.61M-32.56%89.05M-19.86%66.38M-12.43%132.04M10.28%82.83M
Minority profit 354.40%14.68M6.27%5.97M-17.56%3.23M10.75%5.61M-67.73%3.92M-8.85%5.07M-52.86%12.14M-59.86%5.56M33.66%25.76M11.04%13.85M
Profit attributable to shareholders 10.45%98.19M4.17%52.93M11.05%88.9M4.67%50.81M4.09%80.05M-20.19%48.54M-27.64%76.91M-11.82%60.82M-19.18%106.28M10.13%68.98M
Basic earnings per share 10.58%0.1155.08%0.06210.64%0.1043.51%0.0594.44%0.094-19.72%0.057-27.42%0.09-12.35%0.071-21.02%0.1246.58%0.081
Diluted earnings per share 10.58%0.1155.08%0.06210.64%0.1043.51%0.0594.44%0.094-19.72%0.057-27.42%0.09-12.35%0.071-21.02%0.1246.58%0.081
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More